ConductScience.org, home

Cell line · CVCL_A794

Papers15

7 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
HTS384 NCI60: The Next Phase of the NCI60 Screen.Cancer Res2024Cellosaurus cites it, and its Methods give the RRID and name the linePubMed
Human leukemia cells (HL-60) proteomic and biological signatures underpinning cryo-damage are differentially modulated by novel cryo-additives.Gigascience2019Its Methods give the RRID and name the linePubMed
A map of mobile DNA insertions in the NCI-60 human cancer cell panel.Mob DNA2016Cellosaurus cites itPubMed
Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR.Sci Data2016Cellosaurus cites itPubMed
The metabolic demands of cancer cells are coupled to their size and protein synthesis rates.Cancer Metab2013Cellosaurus cites itPubMed
Global proteome analysis of the NCI-60 cell line panel.Cell Rep2013Cellosaurus cites itPubMed
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.Cancer Res2013Cellosaurus cites itPubMed
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.Science2012Cellosaurus cites itPubMed
Identification of cancer cell-line origins using fluorescence image-based phenomic screening.PLoS One2012Cellosaurus cites itPubMed
DNA fingerprinting of the NCI-60 cell line panel.Mol Cancer Ther2009Cellosaurus cites itPubMed
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.Mol Cancer Ther2006Cellosaurus cites itPubMed
HLA class I and II genotype of the NCI-60 cell lines.J Transl Med2005Cellosaurus cites itPubMed
Systematic variation in gene expression patterns in human cancer cell lines.Nat Genet2000Cellosaurus cites itPubMed
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.Cancer Res1997Cellosaurus cites itPubMed
Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.J Natl Cancer Inst1991Cellosaurus cites itPubMed

cell-lines-2026-11-14-0.1.0

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_A794/papers